GenSci120 Injection
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GenSci120 Injection, covering 2026-02-20 to 2026-02-20. Get the full timeline:
Most recent: Clinical Trial Update: Phase IIb Clinical Study to Assess the Efficacy and Safety of GenSci120 Injection in Patients With Moderately to Severely Active RA Who Have an Inadequate Response to at Least One DMARD [Phase 2]